Asker Healthcare Group AB (publ) (STO:ASKER)
78.40
+1.85 (2.42%)
Jul 28, 2026, 5:29 PM CET
Asker Healthcare Group AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18,012 | 16,787 | 15,025 | 13,453 | 11,718 | 9,354 | |
Revenue Growth | 13.41% | 11.73% | 11.68% | 14.81% | 25.27% | - |
Cost of Revenue | 10,571 | 9,916 | 9,147 | 8,934 | 7,936 | 6,741 |
Gross Profit | 7,442 | 6,871 | 5,879 | 4,519 | 3,782 | 2,613 |
Selling, General & Admin | 6,281 | 5,799 | 4,851 | 3,886 | 2,674 | 1,778 |
Depreciation & Amortization Expenses | - | - | - | - | 395 | 230 |
Other Operating Expenses | -21 | 63 | 62 | 54 | 5 | 7 |
Total Operating Expenses | 6,260 | 5,862 | 4,913 | 3,940 | 3,074 | 2,015 |
Operating Income | 1,182 | 1,009 | 966 | 579 | 708 | 598 |
Interest Income | 219 | 222 | 110 | 80 | 266 | 133 |
Interest Expense | -504 | -572 | -517 | -352 | -413 | -187 |
Total Non-Operating Income (Expense) | -285 | -350 | -407 | -272 | -147 | -54 |
Pretax Income | 894 | 659 | 559 | 308 | 561 | 544 |
Provision for Income Taxes | 190 | 149 | 183 | 103 | 127 | 74 |
Net Income | 704 | 510 | 376 | 205 | 434 | 470 |
Minority Interest in Earnings | 20 | 18 | 15 | 2 | 4 | 3 |
Net Income to Common | 684 | 492 | 360 | 203 | 430 | 467 |
Net Income Growth | 69.73% | 36.67% | 77.34% | -52.79% | -7.92% | - |
Shares Outstanding (Basic) | 383 | 368 | 321 | 262 | 258 | 236 |
Shares Outstanding (Diluted) | 383 | 368 | 321 | 262 | 258 | 236 |
Shares Change | 13.56% | 14.59% | 22.56% | 1.55% | 9.55% | - |
EPS (Basic) | 1.78 | 1.25 | 0.74 | 0.77 | 1.67 | 1.98 |
EPS (Diluted) | 1.78 | 1.25 | 0.74 | 0.77 | 1.67 | 1.98 |
EPS Growth | 95.60% | 68.92% | -3.90% | -53.77% | -15.93% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,518 | 1,328 | 1,227 | 1,052 | 976 | 382 |
Free Cash Flow Growth | 51.50% | 8.23% | 16.63% | 7.79% | 155.50% | - |
Free Cash Flow Per Share | 3.96 | 3.61 | 3.82 | 4.01 | 3.78 | 1.62 |
Dividends Per Share | 0.390 | 0.390 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 41.32% | 40.93% | 39.13% | 33.59% | 32.28% | 27.93% |
Operating Margin | 6.56% | 6.01% | 6.43% | 4.30% | 6.04% | 6.39% |
Profit Margin | 3.91% | 3.04% | 2.50% | 1.52% | 3.70% | 5.02% |
FCF Margin | 8.43% | 7.91% | 8.17% | 7.82% | 8.33% | 4.08% |
EBITDA | 1,182 | 1,009 | 966 | 1,127 | 708 | 598 |
EBITDA Margin | 6.56% | 6.01% | 6.43% | 8.38% | 6.04% | 6.39% |
EBIT | 1,182 | 1,009 | 966 | 579 | 708 | 598 |
EBIT Margin | 6.56% | 6.01% | 6.43% | 4.30% | 6.04% | 6.39% |
Effective Tax Rate | 21.25% | 22.61% | 32.74% | 33.44% | 22.64% | 13.60% |